242 related articles for article (PubMed ID: 23077670)
1. Pleiotrophin (PTN) expression and function and in the mouse mammary gland and mammary epithelial cells.
Rosenfield SM; Bowden ET; Cohen-Missner S; Gibby KA; Ory V; Henke RT; Riegel AT; Wellstein A
PLoS One; 2012; 7(10):e47876. PubMed ID: 23077670
[TBL] [Abstract][Full Text] [Related]
2. Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin.
Stoica GE; Kuo A; Aigner A; Sunitha I; Souttou B; Malerczyk C; Caughey DJ; Wen D; Karavanov A; Riegel AT; Wellstein A
J Biol Chem; 2001 May; 276(20):16772-9. PubMed ID: 11278720
[TBL] [Abstract][Full Text] [Related]
3. Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase.
Bowden ET; Stoica GE; Wellstein A
J Biol Chem; 2002 Sep; 277(39):35862-8. PubMed ID: 12107166
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic lymphoma kinase: "Ligand Independent Activation" mediated by the PTN/RPTPβ/ζ signaling pathway.
Deuel TF
Biochim Biophys Acta; 2013 Oct; 1834(10):2219-23. PubMed ID: 23777859
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.
Grzelinski M; Steinberg F; Martens T; Czubayko F; Lamszus K; Aigner A
Neoplasia; 2009 Feb; 11(2):145-56. PubMed ID: 19177199
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation.
Perez-Pinera P; Zhang W; Chang Y; Vega JA; Deuel TF
J Biol Chem; 2007 Sep; 282(39):28683-28690. PubMed ID: 17681947
[TBL] [Abstract][Full Text] [Related]
7. CD151 represses mammary gland development by maintaining the niches of progenitor cells.
Yin Y; Deng X; Liu Z; Baldwin LA; Lefringhouse J; Zhang J; Hoff JT; Erfani SF; Rucker EB; O'Connor K; Liu C; Wu Y; Zhou BP; Yang XH
Cell Cycle; 2014; 13(17):2707-22. PubMed ID: 25486358
[TBL] [Abstract][Full Text] [Related]
8. Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration.
Bray K; Gillette M; Young J; Loughran E; Hwang M; Sears JC; Vargo-Gogola T
Breast Cancer Res; 2013; 15(5):R91. PubMed ID: 24074261
[TBL] [Abstract][Full Text] [Related]
9. Using 3D Culture of Primary Mammary Epithelial Cells to Define Molecular Entities Required for Acinus Formation: Analyzing MAP Kinase Phosphatases.
Gajewska M; McNally S
Methods Mol Biol; 2017; 1501():199-216. PubMed ID: 27796954
[TBL] [Abstract][Full Text] [Related]
10. Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor.
Stylianou DC; Auf der Maur A; Kodack DP; Henke RT; Hohn S; Toretsky JA; Riegel AT; Wellstein A
Oncogene; 2009 Sep; 28(37):3296-306. PubMed ID: 19633684
[TBL] [Abstract][Full Text] [Related]
11. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
[TBL] [Abstract][Full Text] [Related]
12. PTN-PTPRZ signalling is involved in deer antler stem cell regulation during tissue regeneration.
J Cell Physiol; ; . PubMed ID: 33111346
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]